Tectonic Therapeutic, Inc. announced that it has entered into a subscription agreement with certain institutional investors including Tas Partners, LLC to issue 7,790,889 common shares at a price of $12.39908 per shar for the gross proceeds of $96,599,855.98212 on January 30, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.47 USD | -0.12% | -3.17% | +0.92% |
20/06 | Avrobio Closes Merger With Tectonic Therapeutic | MT |
20/06 | Tectonic Therapeutic, Inc. announced that it has received $96.599856 million in funding from Tas Partners, LLC | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.92% | 24Cr | |
+15.20% | 12TCr | |
+19.67% | 11TCr | |
+18.95% | 2.6TCr | |
-23.86% | 1.94TCr | |
-19.03% | 1.59TCr | |
-20.90% | 1.51TCr | |
-46.14% | 1.51TCr | |
+63.85% | 1.49TCr | |
+4.49% | 1.39TCr |
- Stock Market
- Equities
- AVRO Stock
- News Tectonic Therapeutic, Inc.
- Tectonic Therapeutic, Inc. announced that it expects to receive $96.599856 million in funding from Tas Partners, LLC